150 related articles for article (PubMed ID: 17094444)
1. New molecular mechanisms of action of camptothecin-type drugs.
Legarza K; Yang LX
Anticancer Res; 2006; 26(5A):3301-5. PubMed ID: 17094444
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to topoisomerase I-targeting drugs.
Rasheed ZA; Rubin EH
Oncogene; 2003 Oct; 22(47):7296-304. PubMed ID: 14576839
[TBL] [Abstract][Full Text] [Related]
3. Novel camptothecin derivatives as topoisomerase I inhibitors.
Basili S; Moro S
Expert Opin Ther Pat; 2009 May; 19(5):555-74. PubMed ID: 19441934
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of cancer cells to DNA damaging agents by imidazolines.
Sharma V; Peddibhotla S; Tepe JJ
J Am Chem Soc; 2006 Jul; 128(28):9137-43. PubMed ID: 16834387
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines.
Brea-Calvo G; Rodríguez-Hernández A; Fernández-Ayala DJ; Navas P; Sánchez-Alcázar JA
Free Radic Biol Med; 2006 Apr; 40(8):1293-302. PubMed ID: 16631519
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of adenine nucleotide translocase 3 and its role in camptothecin-induced apoptosis in human hepatoma QGY7703 cells.
Hu Z; Guo X; Yu Q; Qiu L; Li J; Ying K; Guo C; Zhang J
FEBS Lett; 2009 Jan; 583(2):383-8. PubMed ID: 19111545
[TBL] [Abstract][Full Text] [Related]
8. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
9. New insights on oxidative stress in cancer.
Visconti R; Grieco D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
[TBL] [Abstract][Full Text] [Related]
10. Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.
Togano T; Sasaki M; Watanabe M; Nakashima M; Tsuruo T; Umezawa K; Higashihara M; Watanabe T; Horie R
Biochem Biophys Res Commun; 2009 Dec; 390(1):60-4. PubMed ID: 19778522
[TBL] [Abstract][Full Text] [Related]
11. An overview on the development of new potentially active camptothecin analogs against cancer.
Chazin Ede L; Reis Rda R; Junior WT; Moor LF; Vasconcelos TR
Mini Rev Med Chem; 2014; 14(12):953-62. PubMed ID: 25355593
[TBL] [Abstract][Full Text] [Related]
12. Topoisomerase I Inhibitors.
Ewesuedo RB; Ratain MJ
Oncologist; 1997; 2(6):359-364. PubMed ID: 10388070
[TBL] [Abstract][Full Text] [Related]
13. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors.
Ying V; Haverstick K; Page RL; Saltzman WM
J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886
[TBL] [Abstract][Full Text] [Related]
15. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
16. A novel camptothecin analog with enhanced antitumor activity.
Yount G; Yang Y; Wong B; Wang HJ; Yang LX
Anticancer Res; 2007; 27(5A):3173-8. PubMed ID: 17970058
[TBL] [Abstract][Full Text] [Related]
17. Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents.
Keyomarsi K; Pardee AB
Prog Cell Cycle Res; 2003; 5():527-32. PubMed ID: 14593747
[TBL] [Abstract][Full Text] [Related]
18. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
19. Modulation of apoptosis signaling for cancer therapy.
Fulda S; Debatin KM
Arch Immunol Ther Exp (Warsz); 2006; 54(3):173-5. PubMed ID: 16652217
[TBL] [Abstract][Full Text] [Related]
20. A promising camptothecin derivative: Semisynthesis, antitumor activity and intestinal permeability.
Rodríguez-Berna G; Mangas-Sanjuán V; Gonzalez-Alvarez M; Gonzalez-Alvarez I; García-Giménez JL; Díaz Cabañas MJ; Bermejo M; Corma A
Eur J Med Chem; 2014 Aug; 83():366-73. PubMed ID: 24980118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
